In this episode of Med Tech Talks, Robert Klupacs CEO of the Bionics Institute, a world leader in the development of medical devices, talks to Professor Michelle McIntosh, Director of the Medicines Manufacturing Innovation Centre and Theme Leader at the Monash Institute of Pharmaceutical Sciences. MIPS was recently named #1 in the QS world university rankings for pharmaceutical sciences for 2022.

Professor McIntosh is an award-winning scientist who is known for her inhaled oxytocin research, which aims to transform maternal healthcare, particularly in developing countries where price, injecting capabilities and cold-storage capabilities may present barriers to safe and effective childbirth.

Professor McIntosh's career has seen her win numerous awards, such as the Monash Vice-Chancellor’s award for Excellence in Research Impact . She has presented her work on inhaled oxytocin to the United Nations General Assembly in New York and her work was recognised former US Secretary of State and presidential candidate, Hilary Clinton.

In this episode you will hear about:

Michelle's journey from PhD student to acclaimed scientist at MIPS
Some insights into her research and the potential of inhaled oxytocin to transform maternal healthcare in developing countries
Michelle's thoughts on building Australia from innovation

More information:
Take a look at the Monash Institute of Pharmaceutical Sciences website: MIPS

Take a look at Professor Michelle McIntosh's Monash University Profile: Professor Michelle McIntosh

To find out more about commercialisation of research through medical device spin-off companies at the Bionics Institute, go to: Our Impact

Updated version 05/08/22

Transforming maternal healthcare with Professor Michelle McIntosh